MX2012008845A - Metodo para sellado de fibrina mejorado. - Google Patents
Metodo para sellado de fibrina mejorado.Info
- Publication number
- MX2012008845A MX2012008845A MX2012008845A MX2012008845A MX2012008845A MX 2012008845 A MX2012008845 A MX 2012008845A MX 2012008845 A MX2012008845 A MX 2012008845A MX 2012008845 A MX2012008845 A MX 2012008845A MX 2012008845 A MX2012008845 A MX 2012008845A
- Authority
- MX
- Mexico
- Prior art keywords
- solid
- fibrin
- fibrinogen
- liquid
- tissue
- Prior art date
Links
- 108010073385 Fibrin Proteins 0.000 title claims abstract description 111
- 102000009123 Fibrin Human genes 0.000 title claims abstract description 111
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 title claims abstract description 111
- 229950003499 fibrin Drugs 0.000 title claims abstract description 111
- 238000007789 sealing Methods 0.000 title claims abstract description 71
- 238000000034 method Methods 0.000 title claims description 78
- 239000011159 matrix material Substances 0.000 claims abstract description 41
- 230000007547 defect Effects 0.000 claims abstract description 33
- 239000000203 mixture Substances 0.000 claims description 187
- 239000000306 component Substances 0.000 claims description 181
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 claims description 176
- 239000007788 liquid Substances 0.000 claims description 154
- 239000007787 solid Substances 0.000 claims description 145
- 108010049003 Fibrinogen Proteins 0.000 claims description 142
- 102000008946 Fibrinogen Human genes 0.000 claims description 142
- 229940012952 fibrinogen Drugs 0.000 claims description 142
- 238000009472 formulation Methods 0.000 claims description 105
- 229960004072 thrombin Drugs 0.000 claims description 73
- 108090000190 Thrombin Proteins 0.000 claims description 72
- 108091005804 Peptidases Proteins 0.000 claims description 32
- 102000035195 Peptidases Human genes 0.000 claims description 30
- 210000004204 blood vessel Anatomy 0.000 claims description 20
- 238000001035 drying Methods 0.000 claims description 20
- 239000004744 fabric Substances 0.000 claims description 20
- 238000001914 filtration Methods 0.000 claims description 19
- 208000032843 Hemorrhage Diseases 0.000 claims description 18
- 239000000126 substance Substances 0.000 claims description 11
- 238000011282 treatment Methods 0.000 claims description 10
- 230000000740 bleeding effect Effects 0.000 claims description 8
- 230000002265 prevention Effects 0.000 claims description 5
- 239000012503 blood component Substances 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 abstract description 101
- 210000004877 mucosa Anatomy 0.000 abstract description 23
- 238000002360 preparation method Methods 0.000 abstract description 9
- 239000000243 solution Substances 0.000 description 29
- 239000000565 sealant Substances 0.000 description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 26
- 239000000843 powder Substances 0.000 description 17
- 238000012360 testing method Methods 0.000 description 15
- 239000012530 fluid Substances 0.000 description 13
- 206010052428 Wound Diseases 0.000 description 12
- 230000002787 reinforcement Effects 0.000 description 12
- 208000027418 Wounds and injury Diseases 0.000 description 11
- 238000004108 freeze drying Methods 0.000 description 11
- 230000002496 gastric effect Effects 0.000 description 11
- 210000003405 ileum Anatomy 0.000 description 11
- 210000002381 plasma Anatomy 0.000 description 11
- 238000001356 surgical procedure Methods 0.000 description 11
- 108010088751 Albumins Proteins 0.000 description 10
- 102000009027 Albumins Human genes 0.000 description 10
- 230000003872 anastomosis Effects 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 239000000463 material Substances 0.000 description 10
- 229910052782 aluminium Inorganic materials 0.000 description 9
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 9
- 210000000936 intestine Anatomy 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 241000700605 Viruses Species 0.000 description 8
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 8
- 239000002953 phosphate buffered saline Substances 0.000 description 8
- 238000000859 sublimation Methods 0.000 description 8
- 230000008022 sublimation Effects 0.000 description 8
- 108010047303 von Willebrand Factor Proteins 0.000 description 8
- 102100036537 von Willebrand factor Human genes 0.000 description 8
- 229960001134 von willebrand factor Drugs 0.000 description 8
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 7
- 108010071289 Factor XIII Proteins 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 229940012444 factor xiii Drugs 0.000 description 7
- 210000000056 organ Anatomy 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
- 239000001110 calcium chloride Substances 0.000 description 6
- 229910001628 calcium chloride Inorganic materials 0.000 description 6
- 235000011148 calcium chloride Nutrition 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 210000004400 mucous membrane Anatomy 0.000 description 6
- 239000003106 tissue adhesive Substances 0.000 description 6
- 239000003981 vehicle Substances 0.000 description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 210000003238 esophagus Anatomy 0.000 description 5
- 230000000968 intestinal effect Effects 0.000 description 5
- 238000007683 laparoscopic Roux-en-Y gastric bypass Methods 0.000 description 5
- 239000012931 lyophilized formulation Substances 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 230000002980 postoperative effect Effects 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 238000002271 resection Methods 0.000 description 5
- 210000004872 soft tissue Anatomy 0.000 description 5
- 239000011343 solid material Substances 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 229960003766 thrombin (human) Drugs 0.000 description 5
- 239000008215 water for injection Substances 0.000 description 5
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 4
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 4
- 108010054218 Factor VIII Proteins 0.000 description 4
- 102000001690 Factor VIII Human genes 0.000 description 4
- 102100037362 Fibronectin Human genes 0.000 description 4
- 108010067306 Fibronectins Proteins 0.000 description 4
- 206010019909 Hernia Diseases 0.000 description 4
- 108010031318 Vitronectin Proteins 0.000 description 4
- 102100035140 Vitronectin Human genes 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 4
- 239000003114 blood coagulation factor Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000015271 coagulation Effects 0.000 description 4
- 238000005345 coagulation Methods 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 229960000301 factor viii Drugs 0.000 description 4
- 230000002779 inactivation Effects 0.000 description 4
- 239000012669 liquid formulation Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 210000000813 small intestine Anatomy 0.000 description 4
- 239000004471 Glycine Substances 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 102000013566 Plasminogen Human genes 0.000 description 3
- 108010051456 Plasminogen Proteins 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 229960003589 arginine hydrochloride Drugs 0.000 description 3
- 210000000013 bile duct Anatomy 0.000 description 3
- 230000023555 blood coagulation Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 210000001951 dura mater Anatomy 0.000 description 3
- -1 for example Proteins 0.000 description 3
- 238000000227 grinding Methods 0.000 description 3
- 230000002008 hemorrhagic effect Effects 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000008176 lyophilized powder Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 210000000496 pancreas Anatomy 0.000 description 3
- 210000000277 pancreatic duct Anatomy 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000001509 sodium citrate Substances 0.000 description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 3
- 239000008247 solid mixture Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- 229960000401 tranexamic acid Drugs 0.000 description 3
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 3
- 239000004475 Arginine Substances 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 208000006809 Pancreatic Fistula Diseases 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 108010094028 Prothrombin Proteins 0.000 description 2
- 102100027378 Prothrombin Human genes 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- 206010040102 Seroma Diseases 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 229960003121 arginine Drugs 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 239000000535 fibrinogen concentrate Substances 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 210000004392 genitalia Anatomy 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 208000008384 ileus Diseases 0.000 description 2
- 238000005304 joining Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000002324 minimally invasive surgery Methods 0.000 description 2
- 239000011812 mixed powder Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 238000001728 nano-filtration Methods 0.000 description 2
- 229940012957 plasmin Drugs 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 229940039716 prothrombin Drugs 0.000 description 2
- 210000000664 rectum Anatomy 0.000 description 2
- VGTPCRGMBIAPIM-UHFFFAOYSA-M sodium thiocyanate Chemical compound [Na+].[S-]C#N VGTPCRGMBIAPIM-UHFFFAOYSA-M 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000008174 sterile solution Substances 0.000 description 2
- 210000004876 tela submucosa Anatomy 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 2
- 239000002821 viper venom Substances 0.000 description 2
- 206010058059 Anastomotic complication Diseases 0.000 description 1
- 108010027529 Bio-glue Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010008164 Cerebrospinal fluid leakage Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 208000013875 Heart injury Diseases 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 101001038021 Lonomia obliqua Lopap Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 102000015728 Mucins Human genes 0.000 description 1
- 108010063954 Mucins Proteins 0.000 description 1
- 206010034650 Peritoneal adhesions Diseases 0.000 description 1
- 206010060932 Postoperative adhesion Diseases 0.000 description 1
- 239000008156 Ringer's lactate solution Substances 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 239000010836 blood and blood product Substances 0.000 description 1
- 239000003914 blood derivative Substances 0.000 description 1
- 229940125691 blood product Drugs 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- ZEWYCNBZMPELPF-UHFFFAOYSA-J calcium;potassium;sodium;2-hydroxypropanoic acid;sodium;tetrachloride Chemical compound [Na].[Na+].[Cl-].[Cl-].[Cl-].[Cl-].[K+].[Ca+2].CC(O)C(O)=O ZEWYCNBZMPELPF-UHFFFAOYSA-J 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 230000000112 colonic effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 208000028831 congenital heart disease Diseases 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229940058249 evithrom Drugs 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000001471 fibrinogenolytic effect Effects 0.000 description 1
- 230000020764 fibrinolysis Effects 0.000 description 1
- 229940049370 fibrinolysis inhibitor Drugs 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 210000003736 gastrointestinal content Anatomy 0.000 description 1
- 238000011902 gastrointestinal surgery Methods 0.000 description 1
- 238000002695 general anesthesia Methods 0.000 description 1
- 230000000025 haemostatic effect Effects 0.000 description 1
- 239000002874 hemostatic agent Substances 0.000 description 1
- 229940106780 human fibrinogen Drugs 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 206010022694 intestinal perforation Diseases 0.000 description 1
- 238000002357 laparoscopic surgery Methods 0.000 description 1
- 206010024378 leukocytosis Diseases 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 229960003646 lysine Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 229940051875 mucins Drugs 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229940099990 ogen Drugs 0.000 description 1
- 210000001706 olfactory mucosa Anatomy 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 238000009928 pasteurization Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 229940071643 prefilled syringe Drugs 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000002760 pro-activator Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 238000002694 regional anesthesia Methods 0.000 description 1
- 239000012779 reinforcing material Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 108010070228 surgisis Proteins 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003356 suture material Substances 0.000 description 1
- 210000001258 synovial membrane Anatomy 0.000 description 1
- 108010034963 tachocomb Proteins 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000009864 tensile test Methods 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000011345 viscous material Substances 0.000 description 1
- 210000004127 vitreous body Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/043—Mixtures of macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0015—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0042—Materials resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/0047—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/10—Polypeptides; Proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/10—Polypeptides; Proteins
- A61L24/106—Fibrin; Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
- B65D81/32—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents for packaging two or more different materials which must be maintained separate prior to use in admixture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
- A61L2300/254—Enzymes, proenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/606—Coatings
- A61L2300/608—Coatings having two or more layers
- A61L2300/61—Coatings having two or more layers containing two or more active agents in different layers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/04—Materials for stopping bleeding
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Surgery (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Materials Engineering (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Mechanical Engineering (AREA)
- Composite Materials (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29912710P | 2010-01-28 | 2010-01-28 | |
| PCT/IL2011/000092 WO2011092694A2 (en) | 2010-01-28 | 2011-01-27 | Method for improved fibrin sealing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2012008845A true MX2012008845A (es) | 2012-09-28 |
Family
ID=43923707
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2012008845A MX2012008845A (es) | 2010-01-28 | 2011-01-27 | Metodo para sellado de fibrina mejorado. |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US8962033B2 (enExample) |
| EP (1) | EP2528631B1 (enExample) |
| JP (1) | JP5859461B2 (enExample) |
| KR (1) | KR101786786B1 (enExample) |
| CN (1) | CN102791299B (enExample) |
| AU (1) | AU2011210356B2 (enExample) |
| BR (1) | BR112012018970B1 (enExample) |
| CA (1) | CA2787883C (enExample) |
| DK (1) | DK2528631T3 (enExample) |
| ES (1) | ES2513516T3 (enExample) |
| MX (1) | MX2012008845A (enExample) |
| RU (1) | RU2556960C2 (enExample) |
| WO (1) | WO2011092694A2 (enExample) |
| ZA (1) | ZA201206438B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL234246A0 (en) * | 2014-08-21 | 2014-11-30 | Omrix Biopharmaceuticals Ltd | Stabilized thrombin |
| CA2960589A1 (en) | 2014-09-11 | 2016-03-17 | Omrix Biopharmaceuticals Ltd. | Addition to a medical applicator |
| US9801983B2 (en) * | 2014-12-18 | 2017-10-31 | Cook Medical Technologies Llc | Medical devices for delivering a bioactive to a point of treatment and methods of making medical devices |
| US20170128617A1 (en) * | 2015-11-11 | 2017-05-11 | Ethicon, Inc. | Sealant formulation and uses thereof |
| IL247821A0 (en) | 2016-09-14 | 2017-01-31 | Omrix Biopharmaceuticals Ltd | Adhesive preparations and their use |
| US12115356B2 (en) * | 2019-03-06 | 2024-10-15 | Gambro Lundia Ab | Device and method for the delivery of a thrombin activated fibrin sealant |
| KR102093839B1 (ko) * | 2019-05-28 | 2020-05-04 | (주)다림티센 | 지혈용 조성물 및 이를 포함하는 용기 |
| US11666682B2 (en) * | 2020-08-31 | 2023-06-06 | Ethicon, Inc. | Method of stopping CSF leaks and apparatus therefor |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1776489A (en) | 1928-03-12 | 1930-09-23 | Carolus M Cobb | Powder distributor |
| ATE20824T1 (de) * | 1981-06-25 | 1986-08-15 | Serapharm Gmbh & Co Kg | Angereichertes plasmaderivat zur unterstuetzung von wundverschluss und wundheilung. |
| AT379311B (de) | 1984-03-29 | 1985-12-27 | Immuno Ag | Vorrichtung zur applikation eines gewebeklebstoffes |
| DE3725552A1 (de) | 1987-08-01 | 1989-02-09 | Hoechst Ag | Spruehkopf zum applizieren eines mehrkomponentenmaterials mittels gas |
| DE3843126C3 (de) | 1988-12-22 | 1994-10-06 | Octapharma Ag | Verfahren zur Herstellung eines hochreinen Thrombinkonzentrates |
| US5116315A (en) | 1989-10-03 | 1992-05-26 | Hemaedics, Inc. | Biological syringe system |
| US7208179B1 (en) | 1990-11-27 | 2007-04-24 | The American National Red Cross | Methods for treating disease and forming a supplemented fibrin matrix |
| US5690675A (en) | 1991-02-13 | 1997-11-25 | Fusion Medical Technologies, Inc. | Methods for sealing of staples and other fasteners in tissue |
| US5792835A (en) | 1991-09-05 | 1998-08-11 | Baxter International Inc. | Method of preparing a topical fibrinogen complex |
| WO1993005822A1 (en) | 1991-09-27 | 1993-04-01 | Octapharma Ag | Tissue glue prepared by using cryoprecipitate |
| WO1994007420A1 (fr) | 1992-09-26 | 1994-04-14 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Applicateur d'adhesif destine a des tissus |
| CN1088117A (zh) * | 1992-12-14 | 1994-06-22 | 白求恩医科大学第二临床学院 | 高效生物胶 |
| US5330974A (en) * | 1993-03-01 | 1994-07-19 | Fibratek, Inc. | Therapeutic fibrinogen compositions |
| AT400304B (de) | 1994-02-28 | 1995-12-27 | Immuno Ag | Vorrichtung zur applikation eines mehrkomponenten-gewebeklebstoffes |
| WO1996022115A1 (en) | 1995-01-16 | 1996-07-25 | Baxter International Inc. | Self-supporting sheet-like material of cross-linked fibrin for preventing post operative adhesions |
| AU708165B2 (en) | 1995-06-06 | 1999-07-29 | Interpore International Inc. | Wound sealant preparation and application device and method |
| DE19521324C1 (de) | 1995-06-12 | 1996-10-31 | Immuno Ag | Gewebeklebstoff und Verwendung desselben als Hämostyptikum |
| DE19617369A1 (de) | 1996-04-30 | 1997-11-06 | Immuno Ag | Lagerstabile Fibrinogen-Präparate |
| US6121232A (en) | 1997-01-31 | 2000-09-19 | Omrix Biopharmaceuticals Sa | Stabilized mixture comprising fibrinogen |
| EP0856317A1 (en) | 1997-01-31 | 1998-08-05 | Omrix Biopharmaceuticals S.A. | A stabilized mixture comprising fibrinogen |
| US6461361B1 (en) | 1998-05-01 | 2002-10-08 | Baxter International Inc. | Gas-driven spraying of mixed sealant agents |
| DE19849589C1 (de) | 1998-10-27 | 2000-06-15 | Glatt Process Technology Gmbh | Fibrin-Gewebekleber-Formulierung und Verfahren zu dessen Herstellung |
| ATA49899A (de) | 1999-03-19 | 2002-06-15 | Immuno Ag | Verfahren und vorrichtung zum mischen von komponenten |
| US20050049178A1 (en) * | 1999-07-06 | 2005-03-03 | Oberschwabenklinik Gmbh | Agent for the occlusion of blood vessels |
| US6802822B1 (en) | 2000-03-31 | 2004-10-12 | 3M Innovative Properties Company | Dispenser for an adhesive tissue sealant having a flexible link |
| US6585696B2 (en) | 2000-12-22 | 2003-07-01 | Baxter International, Inc. | Method and apparatus for applying a medically useful multiple component material |
| BRPI0206708B8 (pt) | 2001-01-25 | 2021-06-22 | Nycomed Pharma As | composição sólida, composição para hemostasia, vedação de tecido e colagem de tecido, e, usos de um veículo de colágeno |
| PL205685B1 (pl) | 2001-05-21 | 2010-05-31 | Omrix Biopharm Sa | Sposób in vitro usuwania lub wyodrębniania plazminogenu lub plazminy w obecności fibrynogenu, stałe podłoże powinowactwa do oczyszczania mieszaniny zawierającej fibrynogen i plazminę i/lub plazminogen oraz krioprecypitat |
| EP1742692A4 (en) | 2004-03-17 | 2012-06-27 | Genzyme Corp | ANTI-ADHERENCE SPRAY |
| DE602005013301D1 (de) | 2005-11-22 | 2009-04-23 | Omrix Biopharm Sa | Applikatorvorrichtung zum aufbringen einer mehrkomponenten-flüssigkeit |
| US20080033332A1 (en) | 2006-08-04 | 2008-02-07 | Macphee Martin | Solid dressing for treating wounded tissue |
| ES2649755T3 (es) | 2006-11-02 | 2018-01-15 | Omrix Biopharmaceuticals Ltd. | Procedimiento de micronización |
| EP2011524A1 (en) | 2007-07-02 | 2009-01-07 | Omrix Biopharmaceuticals Ltd. | Fibrin glue with a visualization agent |
| JP5805542B2 (ja) | 2009-02-20 | 2015-11-04 | オムリックス・バイオファーマシューティカルズ・リミテッドＯｍｒｉｘ Ｂｉｏｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ． | 少なくとも２成分の薬物を投与する装置 |
-
2011
- 2011-01-27 MX MX2012008845A patent/MX2012008845A/es active IP Right Grant
- 2011-01-27 RU RU2012136648/15A patent/RU2556960C2/ru not_active IP Right Cessation
- 2011-01-27 DK DK11706629T patent/DK2528631T3/da active
- 2011-01-27 CN CN201180007775.6A patent/CN102791299B/zh not_active Expired - Fee Related
- 2011-01-27 WO PCT/IL2011/000092 patent/WO2011092694A2/en not_active Ceased
- 2011-01-27 AU AU2011210356A patent/AU2011210356B2/en not_active Ceased
- 2011-01-27 ES ES11706629.0T patent/ES2513516T3/es active Active
- 2011-01-27 KR KR1020127022330A patent/KR101786786B1/ko not_active Expired - Fee Related
- 2011-01-27 JP JP2012550567A patent/JP5859461B2/ja not_active Expired - Fee Related
- 2011-01-27 CA CA2787883A patent/CA2787883C/en not_active Expired - Fee Related
- 2011-01-27 BR BR112012018970A patent/BR112012018970B1/pt not_active IP Right Cessation
- 2011-01-27 EP EP20110706629 patent/EP2528631B1/en not_active Not-in-force
- 2011-01-28 US US13/015,999 patent/US8962033B2/en active Active
-
2012
- 2012-08-27 ZA ZA2012/06438A patent/ZA201206438B/en unknown
-
2015
- 2015-01-07 US US14/591,265 patent/US9302026B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2528631A2 (en) | 2012-12-05 |
| WO2011092694A3 (en) | 2011-09-29 |
| CA2787883A1 (en) | 2011-08-04 |
| DK2528631T3 (da) | 2014-09-15 |
| AU2011210356B2 (en) | 2015-05-28 |
| CA2787883C (en) | 2019-02-19 |
| US8962033B2 (en) | 2015-02-24 |
| RU2556960C2 (ru) | 2015-07-20 |
| CN102791299A (zh) | 2012-11-21 |
| KR20120128132A (ko) | 2012-11-26 |
| CN102791299B (zh) | 2014-10-22 |
| ZA201206438B (en) | 2014-01-29 |
| BR112012018970B1 (pt) | 2018-10-30 |
| AU2011210356A1 (en) | 2012-08-23 |
| US9302026B2 (en) | 2016-04-05 |
| JP5859461B2 (ja) | 2016-02-10 |
| EP2528631B1 (en) | 2014-08-06 |
| WO2011092694A8 (en) | 2012-12-13 |
| US20150125440A1 (en) | 2015-05-07 |
| KR101786786B1 (ko) | 2017-10-18 |
| RU2012136648A (ru) | 2014-03-10 |
| JP2013517886A (ja) | 2013-05-20 |
| US20110182991A1 (en) | 2011-07-28 |
| WO2011092694A2 (en) | 2011-08-04 |
| BR112012018970A2 (pt) | 2017-10-10 |
| ES2513516T3 (es) | 2014-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9302026B2 (en) | Method for improved fibrin sealing | |
| Spotnitz et al. | State-of-the-art review: Hemostats, sealants, and adhesives II: Update as well as how and when to use the components of the surgical toolbox | |
| US7052713B2 (en) | Carrier with solid fibrinogen and solid thrombin | |
| US6733774B2 (en) | Carrier with solid fibrinogen and solid thrombin | |
| Emilia et al. | Topical hemostatic agents in surgical practice | |
| AU2004206150B2 (en) | Hemostatic materials | |
| AU2002255220B2 (en) | Carrier with solid fibrinogen and solid thrombin | |
| Kram et al. | Fibrin glue achieves hemostasis in patients with coagulation disorders | |
| CA2640560C (en) | Joining and/or sealing tissues through photo-activated cross-linking of matrix proteins | |
| CN111954545A (zh) | 制备止血组合物的方法 | |
| Lodi et al. | Management of haemostasis in surgery: sealant and glue applications | |
| US20250256005A1 (en) | Flowable paste with ellagic acid-nickel complex and uses thereof for activating coagulation | |
| RU2256448C1 (ru) | Гемостатический клей | |
| RU2275201C2 (ru) | Гемостатический клей | |
| RU2262937C1 (ru) | Гемостатический клей | |
| CN120981258A (zh) | 用于密封组织中的渗漏的止血密封剂粉末 | |
| Lee et al. | Biologic adhesives and hemostatic agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |